Acute rejection : risk factors, management and complications /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hauppauge, NY : Nova Science Publishers, Incorporated, 2012.
Colección:Immunology and immune system disorders.
Surgery--procedures, complications, and results series.
Temas:
Graft rejection.
Transplantation immunology.
Rejet (Biologie)
Greffe (Chirurgie) > Immunologie.
MEDICAL > Surgery > Plastic & Cosmetic.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • ACUTE REJECTION: RISK FACTORS, MANAGEMENT AND COMPLICATIONS
  • ACUTE REJECTION: RISK FACTORS, MANAGEMENT AND COMPLICATIONS
  • Library of Congress Cataloging-in-Publication Data
  • Contents
  • Preface
  • Chapter 1: HLA and Non-HLA Genes Polymorphisms: Susceptibility and Severity in Tunisian Patients with Rheumatoid Arthritis
  • Abstract
  • 1. Introduction
  • 2. Evaluation of Genetic Predisposition to RA
  • 2.1. Prevalence of RA
  • 2.2. Familial Clustering Studies
  • 2.3. Twins Studies
  • 3. Identification of Candidate Genes
  • 3.1. Linkage Studies
  • 3.2. Candidate Gene Association Studies4. Results of Linkage Studies in RA
  • 5. HLA Association With RA
  • 6. Non HLA Candidate Genes Case-control Studies
  • 6.1. Protein Tyrosine Phosphatase Non-Receptor, Type 22 (PTPN22)
  • 6.2. Tumor Necrosis Factor Receptor Type 2 (TNF-R2)
  • 6.3. Peptidyl Arginine Deiminase 4 (PADI 4)
  • 6.4. Fc γ Receptor IIIa (FcγRIIIa)
  • 6.5. Interleukin 1 Receptor Antagonist (IL-1Ra)
  • 6.6. Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4)
  • 6.7. Apo-1/Fas (CD95)
  • 6.8. Adhesion Molecules
  • 7. Patients and Methods
  • 7.1. Patients and Controls7.2. Methods
  • 7.3. Statistical Methods
  • 8. Results
  • 8.1. HLA Typing
  • a/ DRB1 Genotyping
  • b/ DRB1*04 Sub-typing
  • 8.2. PTPN22 Genotyping
  • 8.3. CTLA-4 Genotyping
  • 8.4. Apo-1/Fas Genotyping
  • 8.5. FcγR Genotyping
  • 8.6. Adhesion Molecules Genotyping
  • 8.7. IL1 Family Polymorphisms Genotyping
  • a/ IL1α (C/T -889)
  • b/ IL1Ra (Intron 2)
  • c/ IL1β C/T -511 and C/T +3954
  • 9. Discussion
  • Conclusion
  • Acknowledgment
  • References
  • Chapter 2: Mechanisms, Management and Consequences of Acute Cellular and Antibody Mediated Rejection in Solid Organ and Reconstructive TransplantationAbstract
  • 1. Acute Rejection
  • 2. Kidney Transplantation
  • 2.1 The Banff Classification
  • 2.2 Acute Antibody-Mediated Rejection in Kidney Transplantation
  • 2.3 Acute T-Cell-Mediated Rejection in Kidney Transplantation
  • 2.3.1. Steps in TCMR â€? 3 Signals [12]
  • 3. Pancreas Transplantation
  • 3.1 The Banff Classification
  • 3.2 Acute Antibody-Mediated Rejection in Pancreas Transplantation
  • 3.3 Acute T-Cell-Mediated Rejection in Pancreas Transplantation4. Liver Transplantation
  • 4.1 Banff Schema for Grading of Liver Allograft Rejection
  • 4.2 Acute Antibody-Mediated Rejection in Liver Transplantation
  • 4.3 Acute T-Cell-Mediated Rejection in Liver Transplantation
  • 5. Intestinal and Multivisceral Transplantation
  • 5.2 Acute Antibody-Mediated Rejection in Intestinal Transplantation
  • 5.3 Acute T-Cell-Mediated Rejection in Intestinal Transplantation
  • 6. Vascularized Composite Allotransplantation

Ejemplares similares